Search
for
Sort by
Research 121–150 of 1000+
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System
- Skin
- Ethosome as a potential transdermal drug delivery system
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Repurposed Drugs: Current Trends in Drug Discovery
- Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery
- Dermatolojik Problemler ve COVID-19
- Improvement of dermal and transdermal therapies by nanocarrier-based drug delivery
- A clinical study of cutaneous adverse drug reactions
- Dizziness and rash in an HIV positive man
- Hair Biology and Nutritional Influences
- Hair loss
- Cutaneous manifestations of systemic infection in children
- Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine
- Secondary syphilis presenting with alopecia and leukoderma in a stable HIV-positive patient in a resource-limited setting: a case report
- Dilated tonic pupils with tabes dorsalis in neurosyphilis as first manifestation of HIV/AIDS: a video report
- Harmless Herbs? A Review of the Recent Literature
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Adverse Cutaneous Reactions to Antidepressants
- Acquired scalp alopecia. Part I: A review
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Micro-segmental hair analysis: detailed procedures and applications in forensic toxicology
- Systemic causes of hair loss
- Lithium: one drug, five complications
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Invasomes: Vesicles for Enhanced Skin Delivery of Drugs
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir